Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers report,
Speaker 1: your roundup of companies making moves in the stock market
Speaker 1: harnessing the power of Bloomberg Data. Let's take a look at.
Speaker 2: Some of the stocks on the move today. We can
Speaker 2: do that with bloom Work Equities reported Natalia Canandiavi Natali.
Speaker 2: What are you looking at? Let's start with Intel. The
Speaker 2: ticker is i NTC. The shares are down by almost
Speaker 2: two percent. So it came after Reuters reported that n
Speaker 2: Video holded test that uses Intel's eighteen eight technology to
Speaker 2: produce its chips. We know that recently, and Video reported
Speaker 2: that it tested actually if it could manufacture its own
Speaker 2: chips using this eighteen A production technology. Reuters cited people
Speaker 2: familiar with the matter. As of now, both companies did
Speaker 2: not comment on that. And it's been really critical for
Speaker 2: Intel's turnaround stories. Investors really want to see if this
Speaker 2: story can play out and then we know. In September,
Speaker 2: Nvidia agreed to invest about five billion dollars in Intel
Speaker 2: and said that it will code develop chips for PCs
Speaker 2: and data centers using its technology.
Speaker 1: All right, well, it's really all about the versification of
Speaker 1: chip supply now, right, and Nvidia definitely be challenged in
Speaker 1: that space.
Speaker 2: Right, Let's take a look at another stock. You're looking at.
Speaker 2: Dinavacs tells about that exactly. So the ticker's dvax shares
Speaker 2: are up by thirty eight percent. It came after Sanofi,
Speaker 2: which is a French pharmaceutical company, said that it will
Speaker 2: start a cash tender to offer to acquire all outstanding
Speaker 2: shares a vaccine maker for fifteen point fifty dollars per share.
Speaker 2: Sanofie agreed to buy Dynavags for about two point two
Speaker 2: billion dollars. This deal gives Sanofi access to some vaccines,
Speaker 2: including hepatitis B vaccines. And we know that this is
Speaker 2: also quite a crucial deal for Sanofi because it's struggling
Speaker 2: also to increase performance and to boost its revenue as
Speaker 2: we see lots of challenges in global vaccine market. All right,
Speaker 2: one more, what do you have for us here? It
Speaker 2: is Snowflake. The tickery snow shares are down by two
Speaker 2: point three percent today. It came after the Information reported
Speaker 2: that the software company is in conversations to buy a
Speaker 2: startup called Observe for about one billion dollars. So Observe,
Speaker 2: this is a startup based in California, and it develops
Speaker 2: the so called observatory tools that help developers to track
Speaker 2: how the apps perform or if there are any challenges
Speaker 2: on the software side. And analysts are really excited actually
Speaker 2: about this potential deal because they say it will allow
Speaker 2: the company to compete more closely with companies like Data Bricks,
Speaker 2: So for now it is a pretty solid move. However,
Speaker 2: of course, shares are down fade.
Speaker 1: The stockmover's report from Bloomberg Radio. Check back with us
Speaker 1: throughout the day for the latest roundup of companies making
Speaker 1: news on Wall Street and for the latest market moving headlines.
Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
Speaker 1: dot com, and on Applecarplay and Android Auto with the
Speaker 1: Bloomberg Business app.